Naomi Litchfield | Director Patient Advocacy
Bionical Emas
Appearances:
Day 1 - World Orphan Drug Congress USA 2026 @ 11:30
Why is Collaboration in Expanded Access fundamental to Rare Patient Communities?
-Hear directly from Patients on their journey from diagnosis to treatment
-Discussion on why Expanded Access Education is a multistakeholder responsibility and share useful patient advocacy resources
-Explore patient communities and Industry perspectives of the importance and need to collaborate and co create EAPs
last published: 13/May/26 12:45 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events